F8 and hemophilia A: This was initially supported by anecdotal cases reports of hemophilia A patients that suggest that FVIII-Fc is potentially tolerogenic (68–70); more highly powered clinical trials are in progress (NCT02234323, NCT03093480, and NCT03103542).